CMAC 2011; 13(3) | CMAC

CMAC 2011; 13(3)

Severe pneumonia is associated with high mortality rates, and appropriate severity assessment plays a main role in timely admission to …
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):204-213
PDF

Due to success in antimicrobial therapy of skin and soft tissue infections, current consensus guidelines give less attention to …
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):214-222
PDF

Currently, culture remains a standard diagnostic method for streptococcal infections. However, over the last decade, rapid diagnostic …
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):223-230
PDF

Objective. To determine causative agents of hospitalacquired pneumonia (HAP), their incidence rates, and susceptibility to …
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):231-240
PDF

This article presents data of multicenter open-label randomized clinical trial of clinical and microbiological efficacy and safety of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):241-254
PDF

Infectious complications of pancreatic cysts (PC) is one of the problem of modern medicine due to insufficient data on pharmacokinetic …
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):255-260
PDF

Antimicrobial susceptibility, serotype distribution, and multilocus sequence types of Streptococcus pneumoniae isolated from the …
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):261-266
PDF

It was the first-in-Russia clinical and economic expertise of the micafungin (Mycamin) use in the treatment of adult patients with …
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):267-278
PDF

Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):279-282
PDF